However, we have not been able to find any reference to the combination of Laponite with anti-VEGF antibodies, widely and repeatedly used as a therapeutic target in ocular pathologies of the posterior pole causing blindness, such as age-related macular degeneration or diabetic retinopathy. Here, VEGFA is linked to blindness (disorder).